Association between intensive care unit-acquired dysglycemia and in-hospital mortality.
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Our objective was to quantify the association between intensive care unit-acquired dysglycemia (hyperglycemia, hypoglycemia, and high variability) and in-hospital mortality. DESIGN: Retrospective, observational study. SETTING: eICU Research Institute participating hospitals with an active tele-ICU program between January 1, 2008, and September 30, 2010, representing 784,392 adult intensive care unit patients. PATIENTS: A total of 194,772 patients met inclusion criteria with an intensive care unit length of stay >48 hrs. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Acute Physiology and Chronic Health Evaluation IV standardized mortality ratios were calculated for dysglycemia present at admission and acquired in the intensive care unit. Intensive care unit-acquired dysglycemia was modeled using multivariable modified Poisson regression to account for confounding not incorporated in Acute Physiology and Chronic Health Evaluation. Dysglycemia severity was assessed by the relative risk of in-hospital mortality associated with the maximum, time-weighted average daily glucose; lowest glucose value throughout the intensive care unit stay; and quintiles of variability (coefficient of variation). The association of duration beyond thresholds of dysglycemia on mortality was also modeled. The adjusted relative risk (95% confidence interval) of mortality for the maximum intensive care unit average daily glucose was 1.13 (1.04-1.58), 1.43 (1.30-1.58), 1.63 (1.47-1.81), 1.76 (1.55-1.99), and 1.89 (1.62-2.19) for 110-150 mg/dL, 151-180 mg/dL, 180-240 mg/dL, 240-300 mg/dL, and >300 mg/dL, respectively, compared to patients whose highest average daily glucose was 80-110 mg/dL. The relative risk of mortality for the lowest glucose value was 1.67 (1.37-2.03), 1.53 (1.37-1.70), 1.12 (1.04-1.21), and 1.06 (1.01-1.11) for <20 mg/dL, 20-40 mg/dL, 40-60 mg/dL, and 60-80 mg/dL, respectively, compared to patients whose lowest value was 80-110 mg/dL. The relative risk of mortality increased with greater duration of hyperglycemia and with increased variability. The relative risk for the highest compared to lowest quintile of variability was 1.61 (1.47-1.78). The association of duration of hyperglycemia on mortality was more pronounced with more severe hyperglycemia. CONCLUSIONS: The risk of mortality progressively increased with severity and duration of deviation from euglycemia and with increased variability. These data suggest that severe intensive care unit-acquired hyperglycemia, hypoglycemia, and variability are associated with similar risks of mortality.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These studies showed differing results, which may have been caused by differences in airway pressures in the treatment and control groups (423, 424, 428).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [428]
In the citing paper
“Hyperglycemia (> 180 mg/dL), hypoglycemia and increased glycemic variability are associated with increased mortality in critically ill patients [509–511].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [509]
Citations
Cites
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
A Modified Poisson Regression Approach to Prospective Studies with Binary Data
Zou, G. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh090 · Cited by 9,615
Intensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119
Intensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639 · cited 2×
“Normoglycaemia in Intensive Care Evaluation and Survival Using Glucose Algorithm Regulation (NICE–SUGAR) and other randomized-controlled trials of TGC strategies have demonstrated that targeting TGC does not generally improve outcomes in critically ill patients, but maintaining glycemic control within the target range…”
BackgroundMethodKrinsley, J. S. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.12.1471 · Cited by 1,165
Griesdale, D. E. G., de Souza, R. J., van Dam, R. M., Heyland, D. K., Cook, D. J., Malhotra, A., Dhaliwal, R., Henderson, W. R., Chittock, D. R., Finfer, S., et al. (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.090206 · Cited by 1,096
Glucose Control and Mortality in Critically Ill Patients
Finney, S. J. (2003) · JAMA · doi:10.1001/jama.290.15.2041 · Cited by 1,055
Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysis
Sun, G.-W., Shook, T. L., & Kay, G. L. (1996) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(96)00025-x · Cited by 933 · cited 1×
“Due to the questionable value of bivariable analysis as variable selection criteria, bivariate statistical significance tests were not used to guide inclusion of covariates in the model (27).”
MethodVariability of Blood Glucose Concentration and Short-term Mortality in Critically Ill Patients
Egi, M., Bellomo, R., Stachowski, E., French, C. J., & Hart, G. (2006) · Anesthesiology · doi:10.1097/00000542-200608000-00006 · Cited by 854
Glycemic variability: A strong independent predictor of mortality in critically ill patients.
Krinsley, J. S. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e31818b38d2 · Cited by 729
Cited by
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002255 · Cited by 3,652
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Stress hyperglycemia: an essential survival response!
Marik, P. E., & Bellomo, R. (2013) · Critical Care · doi:10.1186/cc12514 · Cited by 729
Krinsley, J. S., & Preiser, J.-C. (2015) · Critical Care · doi:10.1186/s13054-015-0908-7 · Cited by 174
“A robust literature has demonstrated that hyperglycemia, hypoglycemia and increased glucose variability are independently associated with mortality in diverse cohorts of critically ill patients [12-22] and that diabetic status modulates these relationships [23-25].”
Backgroundvan Vught, L. A., Wiewel, M. A., Klein Klouwenberg, P. M. C., Hoogendijk, A. J., Scicluna, B. P., Ong, D. S. Y., Cremer, O. L., Horn, J., Bonten, M. M. J., Schultz, M. J., et al. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000001650 · Cited by 130
McCall, A. L., Lieb, D. C., Gianchandani, R., MacMaster, H., Maynard, G. A., Murad, M. H., Seaquist, E., Wolfsdorf, J. I., Wright, R. F., & Wiercioch, W. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac596 · Cited by 123
S3-Leitlinie Sepsis – Prävention, Diagnose, Therapie und Nachsorge
Deutsche Sepsis Gesellschaft e., V., Brunkhorst, F. M., Weigand, M. A., Pletz, M. W., Gastmeier, P., Lemmen, S., Meier‐Hellmann, A., Ragaller, M., Weyland, A., Marx, G., et al. (2020) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-020-00685-0 · Cited by 148
Leelarathna, L., English, S. W., Thabit, H., Caldwell, K., Allen, J. M., Kumareswaran, K., Wilinska, M. E., Nodale, M., Mangat, J., Evans, M. L., et al. (2013) · Critical Care · doi:10.1186/cc12838 · Cited by 120
“Abnormalities of glucose metabolism are common in critically ill patients [1,2] and are characterized by hyperglycemia [3-5], hypoglycemia [6,7], and increased glucose variability [8,9], each independently and additively associated with higher adjusted mortality rates [10].”
Prognostic significance of the stress hyperglycemia ratio in critically ill patients
Li, L., Zhao, M., Zhang, Z., Zhou, L., Zhang, Z., Xiong, Y., Zhao, H., & Yao, Y. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-02005-0 · Cited by 133
“Previous study reported that nearly 10% patients admitted to intensive care unit (ICU) suffered from stress hyperglycemia [2].”
BackgroundInfluentialUsefulness of Glycemic Gap to Predict ICU Mortality in Critically Ill Patients With Diabetes
Liao, W.-I., Wang, J., Chang, W., Hsu, C.-W., Chu, C., & Tsai, S. (2015) · Medicine · doi:10.1097/md.0000000000001525 · Cited by 87
Bohé, J., Abidi, H., Brunot, V., Klich, A., Klouche, K., Sédillot, N., Tchénio, X., Quenot, J., Roudaut, J.-B., Mottard, N., et al. (2021) · PubMed Central · doi:10.1007/s00134-021-06526-8 · Cited by 88
Wang, Y. Y., Hu, S., Ying, H., Chen, L., Li, H., Tian, F., & Zhou, Z.-F. (2018) · BMC Endocrine Disorders · doi:10.1186/s12902-018-0268-9 · Cited by 80
“A recent retrospective study analyzed a large database of patients in critical care units [33] and found that TGC (80–110 mg/dL) was associated with the lowest mortality.”
BackgroundSociety for Maternal-Fetal Medicine Consult Series #67: Maternal sepsis
Shields, A. D., Plante, L. A., Pacheco, L. D., & Louis, J. M. (2023) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2023.05.019 · Cited by 92
Patkova, A. R., Joskova, V., Havel, E., Kovařík, M., Kuchařová, M., Zadák, Z., & Hronek, M. (2017) · Advances in Nutrition · doi:10.3945/an.117.015172 · Cited by 86
“(88) also demonstrated that, among ;200,000 critically ill patients, mortality was the lowest in patients with a blood glucose concentration of 80–110 mg/dL.”
BackgroundNear-Continuous Glucose Monitoring Makes Glycemic Control Safer in ICU Patients*
Preiser, J.-C., Lheureux, O., Thooft, A., Brimioulle, S., Goldstein, J., & Vincent, J.-L. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000003157 · Cited by 67
Stress Hyperlactatemia Modifies the Relationship Between Stress Hyperglycemia and Outcome
Kaukonen, K., Bailey, M., Egi, M., Orford, N. R., Glassford, N. J., Marik, P. E., & Bellomo, R. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000214 · Cited by 68
“In some of these studies, increasing levels or longer duration of hyperglycemia have been associated with increasing risk of mortality (1, 5, 7, 8, 18).”
BackgroundAcute kidney injury after liver transplantation: Recent insights and future perspectives
de Haan, J. E., Hoorn, E. J., & de Geus, H. R. H. (2017) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2017.03.004 · Cited by 65
Perioperative Management of Oral Glucose-lowering Drugs in the Patient with Type 2 Diabetes
Preiser, J., Provenzano, B. C., Wasineeart, M., Halenarova, K. W., & Cnop, M. (2020) · Anesthesiology · doi:10.1097/aln.0000000000003237 · Cited by 69
“All are associated with worse outcomes in acutely injured patients.20–22 Badawi et al.22 analyzed a large cohort of critically ill patients from 344 American intensive care units to evaluate the association between intensive care unit–acquired dysglycemia and in-hospital mortality.”
BackgroundExpert consensus on the glycemic management of critically ill patients
Wu, Z., Liu, J., Zhang, D., Kang, K., Zuo, X., Xu, Q., Pan, A., Fang, W., Liu, F., Shang, Y., et al. (2022) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2022.06.001 · Cited by 73
van Vught, L. A., Holman, R., de Jonge, E., de Keizer, N. F., & van der Poll, T. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002590 · Cited by 66
A systematic scoping review on the consequences of stress-related hyperglycaemia
Olariu, E., Pooley, N., Danel, A., Miret, M., & Preiser, J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194952 · Cited by 68
Glucose management in critically ill adults and children
Mesotten, D., Preiser, J., & Kosiborod, M. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00223-5 · Cited by 63
Güven, M., & Gültekin, H. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14129 · Cited by 56
Glycaemic variability, infections and mortality in a medical–surgical intensive care unit
Donati, A., Damiani, E., Domizi, R., Botticelli, L., Castagnani, R., Gabbanelli, V., Nataloni, S., Carsetti, A., Scorcella, C., Adrario, E., et al. (2014) · Critical Care and Resuscitation · doi:10.1016/s1441-2772(23)01437-0 · Cited by 69
Su, Y., Hsu, C., Guo, Y., & Chen, H.-S. (2016) · Diabetes & Metabolism · doi:10.1016/j.diabet.2016.07.036 · Cited by 56
Merlino, G., Smeralda, C. L., Gigli, G. L., Lorenzut, S., Pez, S., Surcinelli, A., Marini, A., & Valente, M. (2020) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-020-02252-y · Cited by 56
Yoo, S., Lee, H., Lee, H., & Ryu, H. G. (2016) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000001632 · Cited by 51
Update on glucose in critical care
Lheureux, O., Prevedello, D., & Preiser, J. (2018) · Nutrition · doi:10.1016/j.nut.2018.06.027 · Cited by 58
“They also strongly suggest using continuous intravenous insulin as the only strategy permitted to efficiently control BG while decreasing the risk for glycemic variations of large variations in glucose in ICUs.”
BackgroundLeelarathna, L., English, S. W., Thabit, H., Caldwell, K., Allen, J. M., Kumareswaran, K., Wilinska, M. E., Nodale, M., Haidar, A., Evans, M. L., et al. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0221 · Cited by 44
“Abnormalities of glucose metabolism are common during critical illness and are associated with adverse outcomes.(1) Studies aimed at intensive glucose control have shown contradictory results with increased rates of hypoglycemia.”
Merlino, G., Pez, S., Gigli, G. L., Sponza, M., Lorenzut, S., Surcinelli, A., Smeralda, C. L., & Valente, M. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.725002 · Cited by 44
Punthakee, Z., Iglesias, P. P., Alonso‐Coello, P., Gich, I. J., India, I., Málaga, G., Jover, R. D., Gerstein, H. C., & Devereaux, P. J. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30205-5 · Cited by 46
Glycemic control in the critically ill: What have we learned since NICE-SUGAR?
Krinsley, J. S. (2015) · Hospital Practice · doi:10.1080/21548331.2015.1066227 · Cited by 43
“These findings were subsequently corroborated in a multicenter observational study including 194,772 patients [35].”
Lu, M., Zuo, Y.-Y., Guo, J., Wen, X., & Kang, Y. M. (2018) · Medicine · doi:10.1097/md.0000000000012138 · Cited by 40
Кirov, М. Y., Владимирович, К. В., Николаевич, П. Д., Щеголев, А. В., Babaev, M. A., Belotserkovskiy, B. Z., Bykov, A. O., Gritsan, A. I., Кулабухов, В. В., Kulikov, A. V., et al. (2023) · Annals of critical care · doi:10.21320/1818-474x-2023-4-7-42 · Cited by 44
The Accuracy of Continuous Glucose Monitoring in the Medical Intensive Care Unit
Tingsarat, W., Buranasupkajorn, P., Khovidhunkit, W., Boonchaya‐anant, P., & Laichuthai, N. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211027590 · Cited by 34
The flux of energy in critical illness and the obesity paradox
Jaitovich, A., & Hall, J. B. (2025) · Physiological Reviews · doi:10.1152/physrev.00029.2024 · Cited by 37
Deutsche Sepsis Gesellschaft e., V., Brunkhorst, F. M., Weigand, M. A., Pletz, M. W., Gastmeier, P., Lemmen, S., Meier‐Hellmann, A., Ragaller, M., Weyland, A., Marx, G., et al. (2020) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-020-00671-6 · Cited by 37
Don’t Sugar Coat It: Glycemic Control in the Intensive Care Unit
Stoudt, K., & Chawla, S. (2018) · Journal of Intensive Care Medicine · doi:10.1177/0885066618801748 · Cited by 34
Anderson, B. M., Wise, B. T., Joshi, M., Castillo, R., O'Toole, R. V., & Richards, J. E. (2021) · Journal of Orthopaedic Trauma · doi:10.1097/bot.0000000000002101 · Cited by 29
Glycemic control: please agree to disagree
Preiser, J., & Straaten, H. M. O. (2016) · Intensive Care Medicine · doi:10.1007/s00134-016-4374-8 · Cited by 29
Treatment thresholds for hyperglycemia in critically ill patients with and without diabetes
Marik, P. E., & Egi, M. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3344-2 · Cited by 28
“and cohort studies in both ICU and hospitalized non-ICU patients have demonstrated a strong association between hyperglycemia and poor clinical outcomes [2].”
BackgroundYang, X., Shi, N., Yao, L., He, W., Zhu, P., Li, S., Li, L., Li, Y., Liu, S., Deng, L., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.998499 · Cited by 29
“039 LOHS, days, median (25-75 percentile) 8 (6-13) 11 (7-17) <0.”
BackgroundInfluentialPrescribed hypocaloric nutrition support for critically-ill adults
Perman, M., Ciapponi, A., Franco, J. V. A., Loudet, C., Crivelli, A., Garrote, V., & Perman, G. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007867.pub2 · Cited by 33
Munekage, M., Yatabe, T., Sakaguchi, M., Kitagawa, H., Tamura, T., Namikawa, T., & Hanazaki, K. (2015) · Journal of Artificial Organs · doi:10.1007/s10047-015-0877-2 · Cited by 27
“In the ICU, hyperglycemia is a risk factor of hospital mortality [3].”
BackgroundMerlino, G., Pez, S., Tereshko, Y., Gigli, G. L., Lorenzut, S., Surcinelli, A., & Valente, M. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.903987 · Cited by 25
“The results of this study are limited by several factors: (1) the retrospective design of the study may produce systematic error and bias; (2) the observed associations are no proofs of causality; thus, our results should be considered as hypothesis generating; (3) the tertile-based analysis might have affected the ad…”
BackgroundResultGuan, X., Chen, D., & Xu, Y. (2024) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2023.12.002 · Cited by 28
“Evidence summary: One recent meta-analysis [ 214 ] (57 RCTs, [ 203–210 ] n = 21,840) showed that ICU patients who received tight glycemic control had a significantly lower all-cause mortality rate (OR = 0.89, 95% CI: 0.80 to 1.00, I 2 = 32%; P = 0.04), a lower rate of infection (OR = 0.65, 95% CI:…”
BackgroundMethodInfluentialWang, X., Cheng, F. T. F., Lam, T. Y. T., Liu, Y., Huang, D., Liu, X., Chen, H., Zhang, L., Ali, Y., Wang, M. H., et al. (2022) · Diabetes Care · doi:10.2337/dc21-1682 · Cited by 22
Schockleber und Cholestase beim kritisch Kranken
Drolz, A., Horvatits, T., Roedl, K., & Fuhrmann, V. (2014) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-013-0320-5 · Cited by 23
Amrein, K., Kachel, N., Fries, H., Hovorka, R., Pieber, T. R., Plank, J., Wenger, U., Lienhardt, B., & Maggiorini, M. (2014) · BMC Endocrine Disorders · doi:10.1186/1472-6823-14-62 · Cited by 28
“and duration of hyperglycemia, hypoglycemia and with higher variability [7].”
BackgroundKim, S. H., Park, K. N., Choi, S. P., Kim, T. Y., Kim, H., Oh, S. H., & Youn, C. S. (2015) · Journal of Critical Care · doi:10.1016/j.jcrc.2015.08.011 · Cited by 23
“It is well known that acute illnesses or injuries can result in hyperglycemia, but it is unclearwhether this phenomenon results from adaptation or a pathologic mechanism [6-8].”
BackgroundGriffing, K. L. (2016) · Clinical Diabetes · doi:10.2337/cd15-0055 · Cited by 21
“After a hypoglycemic event, the likelihood of further episodes of low blood glucose is increased (2,9,12,13).”
BackgroundHunsicker, O., Hessler, K., Krannich, A., Boemke, W., Braicu, E. I., Sehouli, J., Meyer, O. G. J., Prüß, A., Spies, C., & Feldheiser, A. (2018) · Transfusion · doi:10.1111/trf.14627 · Cited by 20
“46 Body mass index (kg/m(2)) 24 (22; 27) 27 (23; 29) 25 (23; 28) 25 (21; 28) 0.”
Firestone, R. L., Parker, P. L., Pandya, K. A., Wilson, M., & Duby, J. J. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000003709 · Cited by 18
Inflammation and vascular dysfunction: The negative synergistic combination of diabetes and COVID‐19
Bolla, A. M., Loretelli, C., Montefusco, L. B., Finzi, G., Abdi, R., Nasr, M. B., Lunati, M. E., Pastore, I., Bonventre, J. V., Nebuloni, M., et al. (2022) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3565 · Cited by 16
Ma, Z., Wu, L., & Huang, Z. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02810-9 · Cited by 21
“Mamtani et al. demonstrated that in critically ill patients, SHR exhibits a U-shaped relationship with both short-term and long-term mortality, with a critical threshold at SHR = 0.96 [25, 26].”
InfluentialTian, J., Zhou, T., Liu, Z., Dong, Y., & Xu, H. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1446714 · Cited by 19
“In addition, there is an ongoing controversy about SIH and prognosis (6, 7).”
BackgroundHypoglycemia and Risk Factors for Death in 13 Years of Pediatric Admissions in Mozambique
Madrid, L., Acácio, S., Nhampossa, T., Lanaspa, M., Sitoe, A., Maculuve, S. A., Mucavele, H., Quintó, L., Sigaúque, B., & Bassat, Q. (2015) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.15-0475 · Cited by 17
The Bitter and the Sweet: Relationship of Lactate, Glucose, and Mortality After Severe Blunt Trauma
Richards, J. E., Mazzeffi, M. A., Massey, M. S., Rock, P., Galvagno, S. M., & Scalea, T. M. (2020) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000005335 · Cited by 19
Yao, Y., Zhao, Y.-H., Zheng, W.-H., & Huang, H. (2022) · PubMed Central · Cited by 16
Perioperative glycemic control: what is worth the effort?
Dell’Aquila, A. M., & Ellger, B. (2013) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0b013e328362d16a · Cited by 16
“And also fluctuations of blood glucose and hypoglycemia correlate with impaired prognosis [1], so ‘dysglycemia’ of any kind appears to be the patient’s foe as, among others, concluded from a database analysis including 784 392 patients [2].”
BackgroundRichards, J. E., Scalea, T. M., Mazzeffi, M. A., Rock, P., & Galvagno, S. M. (2017) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000002626 · Cited by 15
Updates in Glycemic Management in the Hospital
Mongkolpun, W., Provenzano, B. C., & Preiser, J. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1274-7 · Cited by 16
Inter-relationships between gastric emptying and glycaemia: Implications for clinical practice
Murthy, T. A., Chapman, M. J., Jones, K. L., Horowitz, M., & Marathe, C. S. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i5.447 · Cited by 17
Feng, M., & Zhou, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-55504-9 · Cited by 16
Zhang, Q., Xiang, H., Xu, Q., Hu, Z., Xue, Y., Wang, J., & Ji, K. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111598 · Cited by 15
Precision Glycemic Control in the ICU*
Marik, P. E. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000001683 · Cited by 16
“Retrospective and cohort studies in both ICU and hospitalized non-ICU patients have demonstrated a strong association between stress hyperglycemia and poor clinical outcomes (3).”
BackgroundTransition from intravenous to subcutaneous insulin in critically ill adults
Doolin, M. K., Walroth, T. A., Harris, S. A., Whitten, J. A., & Fritschle-Hilliard, A. C. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816629985 · Cited by 13
“While glycemic control has been shown to decrease morbidity and mortality, conflicting data exists regarding the optimal target range for blood glucose (BG) in critically ill adu lts.(1-5,7-9) Due to conflicting results in the literature, professional organizations such as the Society of Critical Care Medicine (SCCM)…”
BackgroundMalglycemia in the critical care setting. Part II: Relative and absolute hypoglycemia
Roberts, G., Krinsley, J. S., Preiser, J., Quinn, S. J., Rule, P. R., Brownlee, M., Umpierrez, G. E., & Hirsch, I. B. (2023) · Journal of Critical Care · doi:10.1016/j.jcrc.2023.154429 · Cited by 13
Koracevic, G. P., Mićić, S., Stojanović, M., Tomasevic, M. V., Kostić, T. L., Koraćević, M., & Janković, I. (2020) · Primary care diabetes · doi:10.1016/j.pcd.2020.09.004 · Cited by 14
Alizadeh, N., Khalili, H., Mohammadi, M., Abdollahi, M. R., & Ala, S. (2016) · International Journal of Clinical Practice · doi:10.1111/ijcp.12795 · Cited by 13
Nagata, M., Kimura, Y., Ishiwata, Y., Takahashi, H., & Yasuhara, M. (2018) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b18-00195 · Cited by 13
Roberts, G., Krinsley, J. S., Preiser, J., Quinn, S. J., Rule, P., Brownlee, M., Schwartz, M. W., Umpierrez, G., & Hirsch, I. B. (2023) · Journal of Critical Care · doi:10.1016/j.jcrc.2023.154327 · Cited by 12
Umbrello, M., Salice, V., Spanu, P., Formenti, P., Barassi, A., d’Eril, G. V. M., & Iapichino, G. (2013) · Clinical Nutrition · doi:10.1016/j.clnu.2013.10.007 · Cited by 13
Rodriguez-Buitrago, A., Attum, B., Okwumabua, E., Enata, N., Evans, A. G., Pennings, J. S., Karacay, B., Rice, M. J., & Obremskey, W. T. (2019) · Injury · doi:10.1016/j.injury.2019.07.028 · Cited by 11
Doola, R., Todd, A. S., Forbes, J. M., Deane, A. M., Presneill, J., & Sturgess, D. J. (2018) · JMIR Research Protocols · doi:10.2196/resprot.9374 · Cited by 13
“Nutrition and adequate glycemic control are key management strategies associated with positive outcomes in the critically ill patient [1-4].”
Backgroundvan Herpt, T. T. W., van Rosmalen, F., Hulsewé, H. P. M. G., van der Horst‐Schrivers, A. N. A., Driessen, M., Jetten, R., Zelis, N., de Galan, B. E., van Kuijk, S. M. J., van der Horst, I. C. C., et al. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01228-1 · Cited by 10
“Glucose concentrations and glucose variability are independent risk factors for ICU and hospital mortality among various ICU populations [14–19].”
BackgroundResultGlycemic control in critically ill: A moving target
Todi, S. K. (2014) · Indian Journal of Critical Care Medicine · doi:10.4103/0972-5229.130574 · Cited by 12
“78).[16] In a study of 18,563 acute myocardial infarction patients, glycemic variability was associated with increased mortality in an unadjusted analysis, though after controlling for various patient factors including mean blood glucose, glycemic variabilty was not an independent predictor of mortality.”
BackgroundHypoglycemia Reduction Strategies in the ICU
Braithwaite, S. S., Bavda, D. B., Idrees, T., Qureshi, F. M., & Soetan, O. T. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0963-3 · Cited by 13
Bila, R., Varo, R., Madrid, L., Sitoe, A., & Bassat, Q. (2018) · Biosensors · doi:10.3390/bios8020043 · Cited by 9
Strilka, R. J., Stull, M. C., Clemens, M. S., McCaver, S. C., & Armen, S. B. (2016) · Theoretical Biology and Medical Modelling · doi:10.1186/s12976-016-0029-2 · Cited by 9
“Optimal SH therapy would minimize glucose variability (GV ) [14–16], prevent hyperglycemia [17, 18], and not cause hypoglycemia [19, 20] because all three factors have a similar mortality risk [21].”
BackgroundKrinsley, J. S. (2014) · Hospital Practice · doi:10.3810/hp.2014.04.1099 · Cited by 9
Strilka, R. J., Armen, S. B., & INDECK, M. C. (2014) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2014.04.023 · Cited by 9
Strilka, R., Sjulin, T., Huprikar, N., Cameron, L., Woody, P. W., & Armen, S. B. (2020) · International Journal of Critical Illness and Injury Science · doi:10.4103/ijciis.ijciis_112_19 · Cited by 7
“The ideal therapy[14] would minimize glucose variability,[15] hyperglycemia,[16] and hypoglycemia[17] because all three metrics (measures of dysglycemia) have similar mortality risks.[18] It is, therefore, important to better understand how IGF affects dysglycemia measures because patient outcomes could be affected.”
BackgroundHyperglycemic Hyperosmolar State
Zadkar, S. R. (2019) · Journal of Research & Innovation in Anesthesia · doi:10.5005/jp-journals-10049-0076 · Cited by 6
Accuracy and Stability of a Subcutaneous Flash Glucose Monitoring System in Critically Ill Patients
Naraba, H., Goto, T., Tokuda, M., Sonoo, T., Nakano, H., Takahashi, Y., Hashimoto, H., & Nakamura, K. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211017203 · Cited by 5
Glycemic control in critically ill surgical patients: risks and benefits
May, A. K., Mukherjee, K., Albaugh, V. L., Richards, J. E., & Rumbaugh, K. A. (2015) · Open Access Surgery · doi:10.2147/oas.s50416 · Cited by 5
“78).(125) This demonstrates the importance of minimizing BG variability while on IIT.”
D’Netto, M. E., Murphy, C. V., Mitchell, A., & Dungan, K. M. (2015) · Hospital Practice · doi:10.1080/21548331.2016.1130584 · Cited by 6
“lead to even greater complications and increased mortality.[8,9] Risk factors for severe hypoglycemia in the intensive care unit (ICU) include older age, comorbidities,”
BackgroundLiu, W., Dong, M., Li, J., Zhang, G., Ju, C. A., Jiang, J., Duan, L., Xiong, D., Huang, B., Zou, Y., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1518746 · Cited by 4
“A criterion of at least one episode of blood glucose concentration above 150 mg/dL (8.3 mmol/L) was established for de fi ning SHG, as this threshold marked the onset of increased mortality risk and was recommended for initiating insulin therapy (5, 20).”
InfluentialYao, F., Zhao, H., Liu, L., Ming, Y., Chen, X., Fang, D., & He, Z. (2025) · BMC Geriatrics · doi:10.1186/s12877-025-06726-7 · Cited by 7
Lebererkrankungen auf der Intensivstation
Roedl, K., & Fuhrmann, V. (2024) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-024-01157-5 · Cited by 5
Endocrine problems in the critically ill 1: diabetes and glycaemic control
Kerr, D. E., Wenham, T., & Munir, A. (2017) · BJA Education · doi:10.1093/bjaed/mkx024 · Cited by 5
Корниенко, Kornienko, E., Ойноткинова, & Oynotkinova, O. S. (2015) · Journal of New Medical Technologies · doi:10.12737/11912 · Cited by 3
“Высокая внутрибольничная смертность от ИМ при СД в первую очередь связана с более частым развитием застойной сердечной недостаточности [13, 20].”
InfluentialAlshaya, A. I., DeGrado, J. R., Lupi, K. E., & Szumita, P. M. (2021) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-021-01325-z · Cited by 3
Zaitoon, H., Matsri, S., Nagler, S., LALOVICH, M. M., DeFronzo, R. A., & Feigin, E. (2026) · Diabetic Medicine · doi:10.1111/dme.70403 · Cited by 2
Wang, Y., Xu, W., Wang, J., Shu, Y., Xin, Y., & Yang, Y. (2025) · PLoS ONE · doi:10.1371/journal.pone.0328812 · Cited by 2
Effect of blood-sugar limitation on intensive care mortality: Intragroup evaluation
Nachtigall, I., Tafelski, S., Tamarkin, A., Rothbart, A., Lange, M., Wegener, F., Balzer, F., Burgos, J. P. L., Wernecke, K., & Spies, C. (2015) · Journal of International Medical Research · doi:10.1177/0300060514566651 · Cited by 2
Glukosemanagement in der Intensivmedizin
Lindner, M., & Elke, G. (2017) · Aktuelle Ernährungsmedizin · doi:10.1055/s-0043-108683 · Cited by 2
“Surviving Sepsis Campaign Ähnlich lauten die aktuellen Empfehlungen der Surviving Sepsis Campaign aus dem Jahre 2012: Blutglukosewerte sollen alle 1–2h gemessen werden, bis die Blutglukosewerte und Insulindosen stabil bleiben; danach 4-stündlich (“Best Practice Statement”) [18].”
BackgroundInfluentialEndocrine and Electrolyte Disorders
Inglis, P., Moretti, E. W., & Funk, D. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-56724-4.00040-x · Cited by 2
Metadata
- Authors
- Badawi, O., Waite, M. D., Fuhrman, S. A., & Zuckerman, I. H.
- Affiliations
- University of Maryland, Baltimore (US)
- ORCID
- Badawi, Omar
- Venue
- Critical Care Medicine
- Published
- 2012-12
- Volume
- 40
- Issue
- 12
- Pages
- 3180-3188
- ISSN
- 0090-3493 (ISSN-L)
- OpenAlex
- W1974957474
- Cited by
- 142
- References
- 29
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 9 · 2023: 13 · 2022: 10 · 2021: 11 · 2020: 10 · 2019: 8 · 2018: 15 · 2017: 11 · 2016: 13 · 2015: 14 · 2014: 11 · 2013: 6 · 2012: 1
- FWCI
- 8.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Intensive Care Unit Cognitive Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- hyperglycemia, hypoglycemia, glycemic variability, in-hospital mortality, critically ill patients, tele-ICU, glucose threshold, mortality risk stratification, ICU length of stay, sepsis, mechanical ventilation
- MeSH terms
- Aged, Aged, 80 and over, Blood Glucose, Female, Humans, Hyperglycemia, Hypoglycemia, Intensive Care Units, Male, Middle Aged, Retrospective Studies, United States, Baltimore, Cohort Studies, Hospital Mortality, Qualitative Research
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.